Last checked at 
28 Mar 2024 12:17
Bellevue HEALTHCARE TRUST plc
LEI: 213800HQ3J3H9YF2UI82
28 March 2024
Director/PDMR Shareholding & Total Voting rights and capital
Bellevue Healthcare Trust Plc announces that the below ordinary redeemable shares have been acquired from the net directors' fees payable for the quarter ended 31 March 2024:
Director | Number of Shares purchased |
J Dixon | 5,993 |
R Grewal | 8,498 |
P Southgate | 2,843 |
T Young | 2,843 |
K Bolsover | 2,843 |
Following these transactions, the above directors' total shareholdings in the Company are as follows:
Director | Total shareholding |
J Dixon | 131,102 |
R Grewal | 165,090 |
P Southgate | 100,723 |
T Young | 37,511 |
K Bolsover | 31,791 |
Enquiries:
Apex Listed Companies Services (UK) Limited | +44 20 3327 9720 |
Company Secretary | |
The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Josephine Dixon | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Bellevue Healthcare Trust Plc | ||||
b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
Identification code |
| |||||
b)
| Nature of the transaction
| Purchase | ||||
c)
| Price(s) and volume(s) | |||||
Price(s) | Volume(s) | |||||
151.4435p per share | 5,993 | |||||
d)
| Aggregated information | |||||
- Aggregated volume | 5,993 | |||||
- Price | Total price £9,076.01 | |||||
e)
| Date of the transaction
| 27 March 2024 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Randeep Grewal | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Bellevue Healthcare Trust Plc | ||||
b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
Identification code |
| |||||
b)
| Nature of the transaction
| Purchase | ||||
c)
| Price(s) and volume(s) | |||||
Price(s) | Volume(s) | |||||
151.4435p per share | 8,498 | |||||
d)
| Aggregated information | |||||
- Aggregated volume | 8,498 | |||||
- Price | Total price £12,869.67 | |||||
e)
| Date of the transaction
| 27 March 2024 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Paul Southgate | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Bellevue Healthcare Trust Plc | ||||
b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
Identification code |
| |||||
b)
| Nature of the transaction
| Purchase | ||||
c)
| Price(s) and volume(s) | |||||
Price(s) | Volume(s) | |||||
151.4435p per share | 2,843 | |||||
d)
| Aggregated information | |||||
- Aggregated volume | 2,843 | |||||
- Price | Total price £4,305.54 | |||||
e)
| Date of the transaction
| 27 March 2024 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Tony Young | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Bellevue Healthcare Trust Plc | ||||
b)
| LEI | 213800HQ3J3H9YF2UI82 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
Identification code |
| |||||
b)
| Nature of the transaction
| Purchase | ||||
c)
| Price(s) and volume(s) | |||||
Price(s) | Volume(s) | |||||
151.4435p per share | 2,843 | |||||
d)
| Aggregated information | |||||
- Aggregated volume | 2,843 | |||||
- Price | Total price £4,305.54 | |||||
e)
| Date of the transaction
| 27 March 2024 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
1
| Details of the person discharging managerial responsibilities / person closely associated
| |||||
a)
| Name
| Kate Bolsover | ||||
2
| Reason for the notification
| |||||
a)
| Position/status
| Director | ||||
b)
| Initial notification /Amendment
| Initial notification | ||||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
| |||||
a)
| Name
| Bellevue Healthcare Trust Plc | ||||
b)
| LEI
|
213800HQ3J3H9YF2UI82 | ||||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
| |||||
a)
| Description of the financial instrument, type of instrument | Redeemable Ordinary Shares | ||||
Identification code |
| |||||
b)
| Nature of the transaction
| Purchase | ||||
c)
| Price(s) and volume(s) | |||||
Price(s) | Volume(s) | |||||
151.4435p per share | 2,843 | |||||
d)
| Aggregated information | |||||
- Aggregated volume | 2,843 | |||||
- Price | Total price £4,305.54 | |||||
e)
| Date of the transaction
| 27 March 2024 | ||||
f)
| Place of the transaction
| London Stock Exchange | ||||
TOTAL VOTING RIGHTS AND CAPITAL
In conformity with the Disclosure Guidance and Transparency Rules, the Company notifies the market of the following:
As at 28 March 2024, the issued share capital of the Company consists of 478,987,196 Ordinary Shares. Of that amount, 16,698,646 Ordinary shares were held in Treasury and 462,288,550 Ordinary shares were in circulation.
Therefore, the total number of voting rights in the Company is 462,288,550 (the 'Figure').
This Figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.
For further information please contact:
Apex Listed Companies Services (UK) LimitedCompany Secretary0203 327 9720
END